[From "Treat to Target" to "Think to Untreat": Therapeutic de-implementation as a new paradigm in systemic lupus erythematosus]

L Chiche; S Jousse-Joulin; N Jourde-Chiche

doi:10.1016/j.revmed.2022.12.001

[From "Treat to Target" to "Think to Untreat": Therapeutic de-implementation as a new paradigm in systemic lupus erythematosus]

Rev Med Interne. 2023 Mar;44(3):101-104. doi: 10.1016/j.revmed.2022.12.001. Epub 2022 Dec 22.

[Article in French]

Authors

L Chiche¹, S Jousse-Joulin², N Jourde-Chiche³

Affiliations

¹ Service de médecine Interne, hôpital Européen, Marseille, France. Electronic address: l.chiche@hopital-europeen.fr.
² Service de rhumatologie, CHU de Brest, univ Brest, Inserm, LBAI, UMR 1227, Brest, France.
³ Centre de néphrologie et transplantation rénale, AP-HM, CHU Conception, Aix-Marseille Université, inserm, INRAE, C2VN, Marseille, France.

PMID: 36566116
DOI: 10.1016/j.revmed.2022.12.001

No abstract available

Keywords: Désescalade thérapeutique.; Lupus érythémateux systémique; Systemic lupus erythematosus; Therapeutic de-implementation.; Treat to Target; Treat to target.

MeSH terms

Humans
Lupus Erythematosus, Systemic* / drug therapy
Lupus Erythematosus, Systemic* / therapy